Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Paracetamol and Dihydrocodeine Tartrate Tablets

Approval Number

国药准字HC20160025

Company澳美製藥廠有限公司

Registration Date

May 26, 2021

Previous Approval Numbers

HC20160025

Drug Information

Generic Name

氨酚双氢可待因片

Dosage Form

片剂

Strength

每片含对乙酰氨基酚500mg与酒石酸双氢可待因10mg

Drug Type

化学药品

Registration Date

May 26, 2021

Expiry Date

May 25, 2026

Company Information

Applicant Company

Company Name澳美製藥廠有限公司

Company Address

香港新界元朗工业村宏富街1&8号澳美制药中心

Manufacturing Company

Company NameBRIGHT FUTURE PHARMACEUTICAL LABORATORIES LIMITED

Company Address

香港新界元朗工业村宏富街1号澳美制药中心

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy